首页> 外文期刊>The Journal of Urology >Prostate biopsy: indications and technique.
【24h】

Prostate biopsy: indications and technique.

机译:前列腺活检:适应症和技术。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: The last decade has seen numerous modifications in the way prostate cancer is diagnosed. We review the current indications for and methods of prostate biopsy. MATERIALS AND METHODS: The English language literature was reviewed regarding major indications for and methods of prostate biopsy. Pertinent peer reviewed articles were collated and analyzed. RESULTS: The most widely accepted indication for prostate biopsy is a prostate specific antigen (PSA) value of greater than 4.0 ng./ml. However, some investigators advocate prostate biopsy for men with a PSA value in the 2.5 to 4.0 ng./ml. range, believing that use of this parameter results in detection of a greater number of cases of curable disease. Age specific PSA range, percent free PSA and presence of prostatic intraepithelial neoplasia or atypia are all considered to be relative indications for prostate biopsy. The current literature describes a trend toward increasing the number of cores obtained and the sites biopsied beyond those of the standard sextant technique. The additional cores in many series are obtained from more lateral regions of the gland. CONCLUSIONS: Although several criteria are used as indications for initial prostate biopsy, all are based on PSA level and/or abnormal digital rectal examination. Future improvements in currently used prostate cancer markers may result in better selection of cases to biopsy. There is no universally accepted technique of prostate gland biopsy. The current literature supports use of more extensive biopsy techniques to increase the likelihood of prostate cancer detection.
机译:目的:在过去的十年中,前列腺癌的诊断方法发生了许多变化。我们回顾了前列腺活检的当前适应症和方法。材料与方法:回顾了英语文献中有关前列腺穿刺活检的主要适应症和方法。整理并分析了相关同行评审的文章。结果:最广泛接受的前列腺活检指征是前列腺特异性抗原(PSA)值大于4.0 ng./ml。但是,一些研究人员主张对PSA值在2.5到4.0 ng./ml的男性进行前列腺活检。范围,认为使用此参数可以检测到更多可治愈的病例。年龄特定的PSA范围,游离PSA百分比以及前列腺上皮内瘤变或异型性存在均被视为前列腺活检的相对适应症。当前文献描述了一种趋势,该趋势是增加获得的核的数量和活检部位超过标准六分仪技术的部位。从腺体的更多侧向区域获得许多系列的附加核心。结论:尽管使用了几种标准作为初始前列腺活检的指征,但所有标准均基于PSA水平和/或直肠指检异常。当前使用的前列腺癌标记物的未来改进可能会导致更好地选择要进行活检的病例。没有普遍接受的前列腺活检技术。当前文献支持使用更广泛的活检技术以增加检测前列腺癌的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号